Medicine
Molecular Markers of Hepatocellular Carcinoma Surveillance
Quick fact
Alpha-fetoprotein (AFP) was first used as a tumor marker for liver cancer in the 1960s, yet its sensitivity is only about 60%, meaning it misses 40% of early-stage HCC cases.
Why this is interesting
When the liver's silent killer strikes, it often does so without a whisper—can a simple blood test catch it before it's too late?